Similar articles

• Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184.

  Cella D, Huang H, Homesley HD, Montag A, Salani R, De Geest K, Lee R, Spirtos NM. Cella D, et al. Gynecol Oncol. 2010 Dec;119(3):538-42. doi: 10.1016/j.ygyno.2010.08.022. Epub 2010 Sep 21. Gynecol Oncol. 2010. PMID: 20863554 Clinical Trial.
• Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma.

  Hidaka T, Nakamura T, Shima T, Yuki H, Saito S. Hidaka T, et al. J Obstet Gynaecol Res. 2006 Jun;32(3):330-7. doi: 10.1111/j.1447-0756.2006.00405.x. J Obstet Gynaecol Res. 2006. PMID: 16764625
• Chemotherapy for ovarian adult granulosa cell tumour with synchronous endometrial adenocarcinoma.

  Ohara N, Teramoto K, Murao S. Ohara N, et al. J Obstet Gynaecol. 2002 Sep;22(5):573-4. doi: 10.1080/014436102760299024. J Obstet Gynaecol. 2002. PMID: 12521449 No abstract available.
• Grave outcome of granulocyte colony-stimulating factor-producing endometrial cancer: a case report and literature review.

  Yamamoto K, Mabuchi S, Yamasaki M, Yoshimura M, Murata Y. Yamamoto K, et al. J Obstet Gynaecol Res. 2013 May;39(5):1107-10. doi: 10.1111/j.1447-0756.2012.02060.x. Epub 2012 Dec 21. J Obstet Gynaecol Res. 2013. PMID: 23279043 Review.
• New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.

  Sehouli J, Koensgen D, Oskay-Ozcelik G, Mustea A. Sehouli J, et al. Crit Rev Oncol Hematol. 2008 Sep;67(3):204-12. doi: 10.1016/j.critrevonc.2008.02.011. Epub 2008 Apr 14. Crit Rev Oncol Hematol. 2008. PMID: 18407513 Review.